HK1138274A1 - Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound - Google Patents
Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compoundInfo
- Publication number
- HK1138274A1 HK1138274A1 HK10104447.9A HK10104447A HK1138274A1 HK 1138274 A1 HK1138274 A1 HK 1138274A1 HK 10104447 A HK10104447 A HK 10104447A HK 1138274 A1 HK1138274 A1 HK 1138274A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compound
- medicine
- novel pyrimidine
- dibenzylamine structure
- dibenzylamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91162007P | 2007-04-13 | 2007-04-13 | |
PCT/JP2008/057058 WO2008129951A1 (ja) | 2007-04-13 | 2008-04-10 | 新規なジベンジルアミン構造を有するピリミジン化合物及びこれを含有する医薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1138274A1 true HK1138274A1 (en) | 2010-08-20 |
Family
ID=39875479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10104447.9A HK1138274A1 (en) | 2007-04-13 | 2010-05-06 | Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound |
Country Status (20)
Country | Link |
---|---|
US (1) | US7659271B2 (xx) |
EP (1) | EP2149563B9 (xx) |
JP (2) | JP5244095B2 (xx) |
KR (1) | KR101501299B1 (xx) |
CN (1) | CN101679309B (xx) |
AU (1) | AU2008241904B2 (xx) |
BR (1) | BRPI0810880A2 (xx) |
CA (1) | CA2683534C (xx) |
DK (1) | DK2149563T3 (xx) |
EA (1) | EA017321B1 (xx) |
ES (1) | ES2533910T3 (xx) |
HK (1) | HK1138274A1 (xx) |
HU (1) | HUE024898T2 (xx) |
IL (1) | IL201402A (xx) |
MX (1) | MX2009010962A (xx) |
NZ (1) | NZ580777A (xx) |
PL (1) | PL2149563T3 (xx) |
PT (1) | PT2149563E (xx) |
TW (1) | TWI439453B (xx) |
WO (1) | WO2008129951A1 (xx) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7750019B2 (en) | 2006-08-11 | 2010-07-06 | Kowa Company, Ltd. | Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same |
US7790737B2 (en) * | 2007-03-13 | 2010-09-07 | Kowa Company, Ltd. | Substituted pyrimidine compounds and their utility as CETP inhibitors |
JP5319457B2 (ja) * | 2008-08-25 | 2013-10-16 | 興和株式会社 | 新規なジベンジルアミン構造を有するピリミジン化合物及びこれを含有する医薬 |
EP2332923A4 (en) * | 2008-09-12 | 2012-08-01 | Kowa Co | PROCESS FOR THE PRODUCTION OF 5- [2- (METHYLTHIO) ETHOXY] AND PYRIMIDINE-2-AMINE |
US8841478B2 (en) | 2008-11-28 | 2014-09-23 | Kowa Company, Ltd. | Method for preparing trans-{4-[(alkylamino) methyl]- cyclohexyl}acetic acid ester |
WO2012046681A1 (ja) | 2010-10-04 | 2012-04-12 | 興和株式会社 | 脂質代謝関連mRNAの発現抑制剤 |
ES2581557T3 (es) | 2010-06-04 | 2016-09-06 | Kowa Company, Ltd. | Derivado de dibencilamina ópticamente activo y procedimiento de fabricación para el mismo |
CN105837401A (zh) | 2010-07-22 | 2016-08-10 | 兴和株式会社 | 光学活性1-溴-1-[3,5-双(三氟甲基)苯基]乙烷的制备方法 |
PL2729142T3 (pl) * | 2011-07-08 | 2018-10-31 | Novartis Ag | Sposób leczenia miażdżycy tętnic u osobników z wysokim poziomem triglicerydów |
US20140303198A1 (en) * | 2011-11-29 | 2014-10-09 | Kowa Company, Ltd. | Agent for inhibiting expression of npc1l1 and/or lipg mrna and agent for preventing and/or treating obesity |
TW201335109A (zh) * | 2011-12-02 | 2013-09-01 | Kowa Co | 光學活性化合物之製造方法 |
JP5555303B2 (ja) * | 2011-12-02 | 2014-07-23 | 興和株式会社 | 光学活性ジベンジルアミン誘導体及びその製造方法 |
WO2013137371A1 (ja) * | 2012-03-15 | 2013-09-19 | 興和株式会社 | 新規ピリミジン化合物及びそれらを含有する医薬 |
WO2014017569A1 (ja) * | 2012-07-26 | 2014-01-30 | 興和株式会社 | 血中ldlを低下させるための医薬 |
KR20160014620A (ko) | 2013-05-31 | 2016-02-11 | 코와 가부시키가이샤 | 디벤질아민 구조를 갖는 피리미딘 화합물의 신규 형태 |
CN104628584B (zh) * | 2013-11-08 | 2017-03-08 | 广州朗圣药业有限公司 | 一种适合工业化的高纯度达泊西汀的制备方法 |
CN106999491A (zh) * | 2014-11-28 | 2017-08-01 | 兴和株式会社 | 医药 |
JP2019131472A (ja) * | 2016-05-31 | 2019-08-08 | 興和株式会社 | 医薬組成物 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2894445B2 (ja) | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Cetp活性阻害剤として有効な化合物 |
GT199900147A (es) | 1998-09-17 | 1999-09-06 | 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas. | |
US6197786B1 (en) | 1998-09-17 | 2001-03-06 | Pfizer Inc | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
US6147090A (en) | 1998-09-17 | 2000-11-14 | Pfizer Inc. | 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines |
JP2003221376A (ja) | 2001-11-21 | 2003-08-05 | Japan Tobacco Inc | Cetp活性阻害剤 |
KR20040083493A (ko) | 2002-02-01 | 2004-10-02 | 화이자 프로덕츠 인크. | 콜레스테릴 에스테르 전달 단백질 억제제의 제어 방출형제약상 제형 |
KR100634195B1 (ko) | 2002-08-30 | 2006-10-16 | 니뽄 다바코 산교 가부시키가이샤 | 디벤질아민 화합물 및 그 의약 용도 |
TWI345568B (en) | 2004-04-02 | 2011-07-21 | Mitsubishi Tanabe Pharma Corp | Tetrahydronaphthyridine derivatives and a process for preparing the same |
EP1737811B1 (en) * | 2004-04-13 | 2016-08-10 | Merck Sharp & Dohme Corp. | Cetp inhibitors |
EP1817297A1 (en) * | 2004-11-23 | 2007-08-15 | Pfizer Products Inc. | Dibenzyl amine compounds and derivatives |
EP1848430B1 (en) | 2004-12-31 | 2017-08-02 | Dr. Reddy's Laboratories Ltd. | Novel benzylamine derivatives as cetp inhibitors |
US8604055B2 (en) | 2004-12-31 | 2013-12-10 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
WO2006098394A1 (ja) | 2005-03-14 | 2006-09-21 | Japan Tobacco Inc. | 脂質吸収抑制方法および脂質吸収抑制剤 |
AU2006299557A1 (en) | 2005-09-30 | 2007-04-12 | Merck Sharp & Dohme Corp. | Cholesteryl ester transfer protein inhibitors |
CA2642130C (en) | 2005-12-28 | 2013-04-02 | Reddy Us Therapeutics, Inc. | Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
KR20080086917A (ko) * | 2005-12-29 | 2008-09-26 | 노파르티스 아게 | 콜레스테릴 에스테르 전달 단백질 (cetp) 억제제로서의피리디닐 아민 유도체 |
PE20071025A1 (es) | 2006-01-31 | 2007-10-17 | Mitsubishi Tanabe Pharma Corp | Compuesto amina trisustituido |
UY30117A1 (es) | 2006-01-31 | 2007-06-29 | Tanabe Seiyaku Co | Compuesto amina trisustituido |
JP5225076B2 (ja) | 2006-04-27 | 2013-07-03 | 田辺三菱製薬株式会社 | チアゾール環を含むカルボン酸誘導体の医薬用途 |
AR060873A1 (es) * | 2006-05-10 | 2008-07-16 | Novartis Ag | Derivados biciclicos como inhibidores de cetp |
US7750019B2 (en) | 2006-08-11 | 2010-07-06 | Kowa Company, Ltd. | Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same |
US7790737B2 (en) | 2007-03-13 | 2010-09-07 | Kowa Company, Ltd. | Substituted pyrimidine compounds and their utility as CETP inhibitors |
-
2008
- 2008-04-10 JP JP2009510828A patent/JP5244095B2/ja not_active Expired - Fee Related
- 2008-04-10 US US12/100,831 patent/US7659271B2/en not_active Expired - Fee Related
- 2008-04-10 DK DK08740159.2T patent/DK2149563T3/en active
- 2008-04-10 PL PL08740159T patent/PL2149563T3/pl unknown
- 2008-04-10 EP EP20080740159 patent/EP2149563B9/en not_active Not-in-force
- 2008-04-10 CA CA2683534A patent/CA2683534C/en not_active Expired - Fee Related
- 2008-04-10 CN CN2008800199910A patent/CN101679309B/zh not_active Expired - Fee Related
- 2008-04-10 MX MX2009010962A patent/MX2009010962A/es active IP Right Grant
- 2008-04-10 ES ES08740159.2T patent/ES2533910T3/es active Active
- 2008-04-10 WO PCT/JP2008/057058 patent/WO2008129951A1/ja active Application Filing
- 2008-04-10 EA EA200970943A patent/EA017321B1/ru not_active IP Right Cessation
- 2008-04-10 HU HUE08740159A patent/HUE024898T2/en unknown
- 2008-04-10 KR KR1020097023309A patent/KR101501299B1/ko not_active IP Right Cessation
- 2008-04-10 BR BRPI0810880A patent/BRPI0810880A2/pt not_active Application Discontinuation
- 2008-04-10 PT PT87401592T patent/PT2149563E/pt unknown
- 2008-04-10 AU AU2008241904A patent/AU2008241904B2/en not_active Ceased
- 2008-04-10 NZ NZ580777A patent/NZ580777A/en not_active IP Right Cessation
- 2008-04-11 TW TW097113365A patent/TWI439453B/zh not_active IP Right Cessation
-
2009
- 2009-10-11 IL IL201402A patent/IL201402A/en active IP Right Grant
-
2010
- 2010-05-06 HK HK10104447.9A patent/HK1138274A1/xx not_active IP Right Cessation
-
2013
- 2013-04-03 JP JP2013077362A patent/JP2013129678A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN101679309A (zh) | 2010-03-24 |
NZ580777A (en) | 2011-05-27 |
WO2008129951A1 (ja) | 2008-10-30 |
ES2533910T3 (es) | 2015-04-15 |
PL2149563T3 (pl) | 2015-06-30 |
KR20100016332A (ko) | 2010-02-12 |
DK2149563T3 (en) | 2015-02-02 |
BRPI0810880A2 (pt) | 2016-07-19 |
EP2149563A1 (en) | 2010-02-03 |
JP2013129678A (ja) | 2013-07-04 |
EP2149563B1 (en) | 2015-01-07 |
PT2149563E (pt) | 2015-02-18 |
IL201402A (en) | 2015-10-29 |
TW200906804A (en) | 2009-02-16 |
EP2149563B9 (en) | 2015-04-22 |
US20090082352A1 (en) | 2009-03-26 |
MX2009010962A (es) | 2009-12-16 |
TWI439453B (zh) | 2014-06-01 |
EA017321B1 (ru) | 2012-11-30 |
CA2683534A1 (en) | 2008-10-30 |
JP5244095B2 (ja) | 2013-07-24 |
CN101679309B (zh) | 2012-02-29 |
EA200970943A1 (ru) | 2010-04-30 |
CA2683534C (en) | 2015-02-24 |
AU2008241904B2 (en) | 2012-06-07 |
KR101501299B1 (ko) | 2015-03-10 |
US7659271B2 (en) | 2010-02-09 |
HUE024898T2 (en) | 2016-02-29 |
EP2149563A4 (en) | 2011-09-07 |
IL201402A0 (en) | 2010-05-31 |
JPWO2008129951A1 (ja) | 2010-07-22 |
AU2008241904A1 (en) | 2008-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1138274A1 (en) | Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound | |
IL215799A (en) | Quinazolone compounds, pharmaceuticals containing them and their uses | |
IL216254A (en) | Compounds, pharmaceutical compositions and their uses | |
IL211400A0 (en) | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof | |
HK1168843A1 (zh) | 取代的喹喔啉型呱啶化合物及其用途 | |
GB0717839D0 (en) | The treepee | |
IL205057A0 (en) | Pyrimidyl indoline compound, composition comprising the same and uses thereof | |
IL207201A0 (en) | Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds and the use thereof | |
GB0702228D0 (en) | The cosy-cushion | |
EP2192122A4 (en) | Dithiolopyrrolone compounds and their preparation and use | |
GB0707146D0 (en) | The bealyboard | |
IL213736A0 (en) | Indanyl compounds, compositions comprising the same and uses thereof | |
GB0701309D0 (en) | The easi-strutt | |
PL383000A1 (pl) | Zaczepy, zwłaszcza półek i sposób ich montażu | |
GB0710701D0 (en) | The kaleidosphere | |
GB0717383D0 (en) | The groom-buddy | |
GB0705727D0 (en) | The degravitator | |
GB0703554D0 (en) | The allotpot | |
GB0710246D0 (en) | The hydra-pack | |
GB0703548D0 (en) | The eco-bench | |
GB0711387D0 (en) | The fincubator | |
GB0711847D0 (en) | The potashe | |
GB0713046D0 (en) | The duveze | |
GB0715363D0 (en) | The karrygrip | |
GB0715394D0 (en) | The NEWO |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190410 |